In their research article published in Eurosurveillance, von Schreeb et al. challenge existing assumptions regarding the relationship between the use of HIV pre-exposure prophylaxis (PrEP) and the ...
LA CAB for PrEP shows high effectiveness and persistence among Black cisgender and transgender women in the United States.
A brand new drug might be more effective at preventing HIV than current methods. Many people take daily oral antiretroviral medication—known as PrEP (pre-exposure prophylaxis)—to protect themselves ...
There was an increase in the annual number of PrEP users from 10,281 in 2013 to 505,730 in 2023. HealthDay News — Preexposure prophylaxis (PrEP) use increased between 2013 and 2023, according to a ...
The Global Fund has committed an additional Sh256 million($2 million) to support Kenya’s rollout of the long-acting HIV preventioninjection, Lenacapavir, officials announced during the national launch ...
MONTRÉAL, March 25, 2025 /CNW/ - ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. (PFE) and Shionogi as shareholders, is pleased to ...
In their research article published in Eurosurveillance, von Schreeb et al. challenge existing assumptions regarding the relationship between the use of HIV pre-exposure prophylaxis (PrEP) and the ...
Generic tenofovir disoproxil fumarate/emtricitabine the most frequently prescribed medication since 2021. (HealthDay News) — Preexposure prophylaxis (PrEP) use increased between 2013 and 2023, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results